Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

TPEX:4111 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	421.85	336.19	381.05	456.25	252.27	335.8
Cash & Short-Term Investments	421.85	336.19	381.05	456.25	252.27	335.8
Cash Growth	31.81%	-11.77%	-16.48%	80.86%	-24.88%	22.02%
Accounts Receivable	345.18	326.5	309.71	282.64	281.4	247.78
Other Receivables	7.19	18.58	19.94	0.66	0.81	1
Receivables	352.37	345.07	329.65	283.3	282.2	248.78
Inventory	100.53	96.85	89.17	99.03	90.25	85.39
Prepaid Expenses	8.65	6.49	4.11	2.23	9.92	13.62
Other Current Assets	22.01	0.02	0.02	16.82	16.83	0.01
Total Current Assets	905.42	784.62	804	857.64	651.47	683.6
Property, Plant & Equipment	709.09	756.98	720.35	785.33	899.42	717.45
Long-Term Investments	1.81	1.81	1.84	3.48	3.97	3.43
Other Intangible Assets	1.63	1.63	1.46	1.04	0.9	0.97
Long-Term Deferred Tax Assets	4	11.23	35.54	54.2	6.1	7.98
Other Long-Term Assets	284.14	193.37	202.92	98.84	97.92	73.3
Total Assets	1,906	1,750	1,766	1,801	1,660	1,487
Accounts Payable	226.18	240.28	226.33	237.03	205.74	188.81
Short-Term Debt	10	10	120	120	130	-
Current Portion of Leases	9.2	9.53	2.12	6.11	6.72	5.49
Current Income Taxes Payable	26.55	1	1.2	18.7	14.01	9.98
Current Unearned Revenue	0	0.14	1.17	4.77	7.79	12.01
Other Current Liabilities	205.12	111.85	100.63	95.29	82.63	76.23
Total Current Liabilities	477.05	372.8	451.46	481.89	446.88	292.53
Long-Term Leases	6.3	7.09	0.78	2.28	7.28	7.04
Pension & Post-Retirement Benefits	3.89	8.89	11.24	9.08	18.61	24.97
Long-Term Deferred Tax Liabilities	76.81	79.94	76.52	77.85	76.52	76.52
Other Long-Term Liabilities	5.84	6.35	7.05	7.29	9.75	9.87
Total Liabilities	569.89	475.08	547.04	578.38	559.04	410.93
Common Stock	598.32	569.83	569.83	569.83	569.83	569.83
Additional Paid-In Capital	48.85	48.85	48.85	48.85	48.85	48.85
Retained Earnings	691.86	658.71	603.19	604.63	506.39	481.54
Comprehensive Income & Other	-2.83	-2.84	-2.8	-1.16	-24.33	-24.43
Shareholders' Equity	1,336	1,275	1,219	1,222	1,101	1,076
Total Liabilities & Equity	1,906	1,750	1,766	1,801	1,660	1,487
Total Debt	25.49	26.62	122.9	128.38	144	12.53
Net Cash (Debt)	396.35	309.57	258.15	327.87	108.27	323.27
Net Cash Growth	46.26%	19.92%	-21.26%	202.84%	-66.51%	24.34%
Net Cash Per Share	6.57	5.15	4.30	5.45	1.80	5.38
Filing Date Shares Outstanding	59.83	59.83	59.83	59.83	59.83	59.83
Total Common Shares Outstanding	59.83	59.83	59.83	59.83	59.83	59.83
Working Capital	428.36	411.82	352.54	375.74	204.59	391.06
Book Value Per Share	22.33	21.30	20.37	20.43	18.40	17.98
Tangible Book Value	1,335	1,273	1,218	1,221	1,100	1,075
Tangible Book Value Per Share	22.31	21.27	20.35	20.41	18.38	17.96
Land	371.9	371.9	371.9	478.28	478.28	242.77
Buildings	652.76	662.04	636.77	538.78	703.06	708.18
Machinery	584.84	585.74	549.8	529.11	569.08	556.68
Construction In Progress	17.33	36.28	30.51	82.48	2.96	-
Leasehold Improvements	3.04	2.44	2.29	3.41	3.41	3.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.